Form: 8-K

Current report

January 30, 2009



 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) of the SECURITIES EXCHANGE ACT OF 1934
 
 
Date of Event Requiring Report: January 28, 2009
 
VERSA CARD, INC.
(Exact name of registrant as specified in its charter)

 
DELAWARE
 
 
(State or other jurisdiction of incorporation or organization)
 
000-27407
98-0187705
(Commission File Number)
(IRS Employer Identification Number)
 
William F. Donovan, M.D., Chief Executive Officer
 
 
5225 Katy Freeway, Suite 600, Houston, TX 77007
(Address of principal executive offices)
 
 
(713) 816-8551
(Registrant’s telephone number, including area code)
 
 
N/A
(Former Name or Former Address, If Changed Since Last Report.)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a - -12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d - -2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e - -4(c))

 
 
 
 


 
Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officers
 
Effective January 28, 2009, the Board of the Company accepted the resignation of Timothy Donovan as the Company’s Interim Chief Executive Officer and appointed William F. Donovan, M.D, as the Company’s Chief Executive Officer. The appointment of Dr. Donovan as the Company’s Chief Executive Officer was not based on any prior understanding or arrangement.

William Donovan, M.D., age 65, is a Director and Secretary of the Company.  He is a Board Certified Orthopedic Surgeon, and has been involved with venture funding and management for over 25 years.  He was the co-founder of DRCA (later known as I.O.I) and became Chairman of this company that went from the pink sheets, to NASDAQ and then to the AMEX before being acquired by a subsidiary of the Bass Family.  He was a founder of “I Need A Doc”, later changed to IP2M that was acquired by Dialog Group, a public traded company.  He was the Chairman of House of Brussels, an international chocolate company and president of ChocoMed, a specialized confectionery company combining Nutraceuticals with chocolate bars.  Dr. Donovan has been practicing in Houston since l975. Throughout his career as a physician, he has been involved in projects with both public and private enterprises. He received his Orthopedic training at Northwestern University in Chicago.  He was a Major in the USAF for 2 years at Wright Patterson Air force base in Dayton, Ohio. He established Northshore Orthopedics in 1975 and continues in active practice in Houston, Texas specializing in Orthopedic Surgery.
 
Item 8.01  
 Other Events

The Company intends to develop or acquire businesses that will focus on the management of musculo-skeletal injuries, including pain management, medical imaging, and surgical evaluation.
 
These activities are in addition to the Company’s activities related to the “Manga” themed web portal, which the Company still holds. The Company is currently interviewing new development teams to complete the MangaPets web portal.
 
This report contains statements about future events and expectations that are characterized as “forward-looking statements.”  Forward-looking statements are based upon management’s beliefs, assumptions, and expectations.  Forward-looking statements involve risks and uncertainties that may cause our actual results, performance, and financial condition to be materially different from the expectations of future results, performance, and financial condition we express or imply in such forward-looking statements.  You are cautioned not to put undue reliance on forward-looking statements.  We disclaim any intent or obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

 
 
 
 


 
Signatures
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  VERSA CARD, INC.  
       
Date: January 28th, 2009
By:
/s/ William F. Donovan, M.D.  
    Name: William F. Donovan, M.D.   
    Title: Chief Executive Officer of Versa Card, Inc.